TNK2 TYROSINE KINASE AS A NOVEL THERAPEUTIC TARGET IN TRIPLE NEGATIVE BREAST CANCER

$567,000FY2015Department of DefenseDOD

The Johns Hopkins University

Investigators

View source on USAspending →